Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

BioMimetic Therapeutics receives response to Augment Bone Graft PMA

Jan. 4, 2012

BioMarin's IND for achondroplasia therapy is active

Jan. 4, 2012

Ampio Pharmaceuticals completes expanded enrollment in Ampion trial

Jan. 4, 2012

Dainippon Sumitomo Pharma synthesizes new Toll-like receptor antagonists

Jan. 4, 2012

Novel tyrosine-protein kinase BTK inhibitors disclosed by Ono Pharmaceutical

Jan. 4, 2012

Novel TNF-alpha production inhibitors presented by scientists in China

Jan. 4, 2012

TiGenix obtains funds for development of rheumatoid arthritis treatment

Dec. 29, 2011

Immunomedics and UCB amend epratuzumab license agreement

Dec. 29, 2011

DV-1179 enters proof-of-mechanism trial

Dec. 28, 2011

FDA accepts tofacitinib NDA for review

Dec. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...